Literature DB >> 13316183

Fatal marrow aplasia after treatment with carbimazole.

C D BURRELL.   

Abstract

Entities:  

Keywords:  BONE MARROW/diseases; THYROID ANTAGONISTS/injurious effects

Mesh:

Substances:

Year:  1956        PMID: 13316183      PMCID: PMC1980002          DOI: 10.1136/bmj.1.4981.1456

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  The low toxicity of carbimazole; a survey of 1,046 patients.

Authors:  C D BURRELL; R FRASER; D DONIACH
Journal:  Br Med J       Date:  1956-06-23

2.  Antithyroid activity and toxicity of mercazole and neo-mercazole.

Authors:  T R FRASER; O GARROD; M G HANNO; A JADRESIC
Journal:  J Clin Endocrinol Metab       Date:  1954-10       Impact factor: 5.958

3.  Toxicity of the antithyroid drug carbimazole.

Authors:  R GREENE; D C MORGAN
Journal:  J Clin Endocrinol Metab       Date:  1956-03       Impact factor: 5.958

4.  Agranulocytosis in a patient treated with carbimazole.

Authors:  A R HARRISON
Journal:  Lancet       Date:  1954-02-20       Impact factor: 79.321

5.  Clinical experience with a new antithyroid drug: 2-carbethoxythio-1-methylglyoxaline.

Authors:  E C BARTELS
Journal:  J Clin Endocrinol Metab       Date:  1953-11       Impact factor: 5.958

6.  Fatal case of marrow aplasia after treatment with carbimazole; the effect of ACTH.

Authors:  J S RICHARDSON; I SARKANY; C D CAMPBELL
Journal:  Br Med J       Date:  1954-02-13
  6 in total
  4 in total

1.  Cross sensitivity to antithyroid drugs.

Authors:  A Smith; R F Gledhill; P Jenkins
Journal:  BMJ       Date:  1989-05-06

2.  Agranulocytosis and antithyroid drugs.

Authors:  M H Rosove
Journal:  West J Med       Date:  1977-05

3.  Pharmacokinetics of methimazole in humans.

Authors:  J H Hengstmann; H Hohn
Journal:  Klin Wochenschr       Date:  1985-12-02

4.  Carbimazole (neo-mercazole) in thyrotoxicosis--a review of sixty patients.

Authors:  M W BOYD
Journal:  Ulster Med J       Date:  1959-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.